Fractyl Health (GUTS) Enterprise Value (2023 - 2026)
Fractyl Health (GUTS) reported Enterprise Value of -$63.2 million for Q1 2026, down 50.04% year-on-year from -$126.4 million in Q1 2025, and up 22.53% quarter-over-quarter from -$81.5 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Enterprise Value data on file, last reported at -$63.2 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 50.04% year-over-year to -$63.2 million; the trailing twelve-month figure through Mar 2026 stood at -$63.2 million (down 50.04% YoY), and the FY2025 full-year result was -$81.5 million, down 20.86% from the prior year.
- Enterprise Value for Q1 2026 stood at -$63.2 million, up from -$81.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$22.3 million in Q2 2025 and bottomed at -$121.8 million in Q1 2024.
- A 4-year average of -$69.7 million and a median of -$72.6 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value slumped 101.24% in 2024 and soared 78.3% in 2025, its largest moves.
- Tracing GUTS's Enterprise Value over 4 years: stood at -$33.5 million in 2023, then slumped by 101.24% to -$67.5 million in 2024, then slipped by 20.86% to -$81.5 million in 2025, then rose by 22.53% to -$63.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$63.2 million, -$81.5 million, and -$77.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | -63.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.17 Mn |
| Dec 31, 2025 | -81.54 Mn |
| Sep 30, 2025 | -77.66 Mn |
| Jun 30, 2025 | -22.30 Mn |
| Mar 31, 2025 | -42.10 Mn |
| Dec 31, 2024 | -67.46 Mn |
| Sep 30, 2024 | -84.66 Mn |
| Jun 30, 2024 | -102.75 Mn |
| Mar 31, 2024 | -121.76 Mn |
| Dec 31, 2023 | -33.52 Mn |